Two Sigma Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.17M | Buy |
87,299
+37,600
| +76% | +$1.68M | ﹤0.01% | 2398 |
|
|
2025
Q4 | $2.31M | Hold |
49,699
| – | – | ﹤0.01% | 2325 |
|
|
2025
Q3 | $2.07M | Sell |
49,699
-3,080
| -6% | -$98.5K | ﹤0.01% | 2104 |
|
|
2025
Q2 | $1.52M | Buy |
+52,779
| New | +$1.63M | ﹤0.01% | 2008 |
|
|
2024
Q4 | – | Sell |
-5,414
| Closed | -$277K | – | 3250 |
|
|
2024
Q3 | $277K | Sell |
5,414
-5,386
| -50% | -$278K | ﹤0.01% | 2703 |
|
|
2024
Q2 | $484K | Sell |
10,800
-108,080
| -91% | -$4.99M | ﹤0.01% | 2390 |
|
|
2024
Q1 | $5.56M | Sell |
118,880
-74,221
| -38% | -$2.9M | 0.01% | 916 |
|
|
2023
Q4 | $6.87M | Sell |
193,101
-208,852
| -52% | -$6.4M | 0.02% | 836 |
|
|
2023
Q3 | $12M | Buy |
401,953
+310,418
| +339% | +$6.4M | 0.03% | 542 |
|
|
2023
Q2 | $1.65M | Buy |
91,535
+59,335
| +184% | +$1.18M | ﹤0.01% | 1590 |
|
|
2023
Q1 | $517K | Buy |
32,200
+7,588
| +31% | +$140K | ﹤0.01% | 2183 |
|
|
2022
Q4 | $450K | Buy |
24,612
+1,356
| +6% | +$23.9K | ﹤0.01% | 2065 |
|
|
2022
Q3 | $457K | Sell |
23,256
-23,489
| -50% | -$479K | ﹤0.01% | 1820 |
|
|
2022
Q2 | $872K | Sell |
46,745
-74,032
| -61% | -$1.48M | ﹤0.01% | 1603 |
|
|
2022
Q1 | $2.65M | Sell |
120,777
-16,515
| -12% | -$334K | 0.01% | 1207 |
|
|
2021
Q4 | $3.9M | Sell |
137,292
-9,000
| -6% | -$222K | 0.01% | 1351 |
|
|
2021
Q3 | $3.08M | Buy |
146,292
+29,982
| +26% | +$627K | 0.01% | 1589 |
|
|
2021
Q2 | $2.19M | Buy |
116,310
+58,366
| +101% | +$1.03M | 0.01% | 1778 |
|
|
2021
Q1 | $885K | Buy |
57,944
+4,033
| +7% | +$62.5K | ﹤0.01% | 2430 |
|
|
2020
Q4 | $761K | Buy |
53,911
+26,834
| +99% | +$374K | ﹤0.01% | 2202 |
|
|
2020
Q3 | $424K | Sell |
27,077
-26,735
| -50% | -$409K | ﹤0.01% | 2362 |
|
|
2020
Q2 | $943K | Buy |
+53,812
| New | +$917K | ﹤0.01% | 1573 |
|
Other funds holding CRNX
FCM
DCM
VCM
VPM
EC